Chapter 26. Polyomavirus-Associated Nephropathy

  1. Donald A. Molony MD4,5 and
  2. Jonathan C. Craig MD, PhD6,7
  1. Fabrizio Ginevri MD1 and
  2. Hans H. Hirsch MD, MS2,3

Published Online: 4 MAR 2009

DOI: 10.1002/9781444303391.ch26

Evidence-Based Nephrology

Evidence-Based Nephrology

How to Cite

Ginevri, F. and Hirsch, H. H. (2008) Polyomavirus-Associated Nephropathy, in Evidence-Based Nephrology (eds D. A. Molony and J. C. Craig), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444303391.ch26

Editor Information

  1. 4

    Division of Renal Disease and Hypertension, University of Texas, USA

  2. 5

    Houston Medical School, Houston, Texas, USA

  3. 6

    School of Public Health, University of Sydney, Australia

  4. 7

    Department of Nephrology, The Children's Hospital at Westmead, Sydney, Australia

Author Information

  1. 1

    Pediatric Nephrology Unit, Istituto G. Gaslini, Genova, Italy

  2. 2

    Transplantation Virology & Molecular Diagnostics, Institute for Medical Microbiology, University of Basel, Basel, Switzerland

  3. 3

    Infectious Diseases & Hospital Epidemiology, University Hospital Basel, Basel, Switzerland

Publication History

  1. Published Online: 4 MAR 2009
  2. Published Print: 5 DEC 2008

ISBN Information

Print ISBN: 9781405139755

Online ISBN: 9781444303391



  • polyomavirus-associated nephropathy (PVAN);
  • pathogenesis of PVAN;
  • PVAN screening, diagnosis, and management in kidney transplant recipients;
  • screening for polyomavirus BKV replication;
  • treatment of PVAN;
  • BKV screening and early intervention;
  • retransplantation after renal allograft loss due to PVAN


This chapter contains sections titled:

  • Introduction

  • Definitions

  • Pathogenesis of PVAN

  • Risk factors

  • Clinical management

  • Perspective

  • References